Maintenance: Thursday, 22 March 2018, 18:00-18:15
Maintenance work on the ZORA servers is provided. There may be short interruptions in the service between 18:00 and 18:15. Thank you for your patience.
Bremer, J; O'Connor, T; Tiberi, C; Rehrauer, H; Weissenberger, J; Aguzzi, A (2010). Ablation of Dicer from murine Schwann cells increases their proliferation while blocking myelination. PLoS ONE, 5(8):e12450.
Weissenberger, J; Loeffler, S; Kappeler, A; Kopf, M; Lukes, A; Afanasieva, T A; Aguzzi, A; Weis, J (2004). IL-6 is required for glioma development in a mouse model. Oncogene, 23(19):3308-3316.
Steinbach, J P; Weissenberger, J; Aguzzi, A (1999). Distinct phases of cryogenic tissue damage in the cerebral cortex of wild-type and c-fos deficient mice. Neuropathology and Applied Neurobiology, 25(6):468-480.
Theurillat, J P; Hainfellner, J A; Maddalena, A; Weissenberger, J; Aguzzi, A (1999). Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice. American Journal of Pathology, 154(2):581-590.
Pohl, U; Wick, W; Weissenberger, J; Steinbach, J P; Dichgans, J; Aguzzi, A; Weller, M (1999). Characterization of Tu-2449, a glioma cell line derived from a spontaneous tumor in GFAP-v-src-transgenic mice: comparison with established murine glioma cell lines. International Journal of Oncology, 15(4):829-834.
Rovigatti, U; Afanasieva, T A; Brandner, S; Hainfellner, J A; Kiess, M; Maddalena, A; Malin, G; Rülicke, T; Steinbach, J; Weissenberger, J; Aguzzi, A (1998). Transgenic mice as research tools in neurocarcinogenesis. Journal of Neurovirology, 4(2):159-174.
Weissenberger, J; Steinbach, J P; Malin, G; Spada, S; Rülicke, T; Aguzzi, A (1997). Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice. Oncogene, 14(17):2005-2013.